S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
NASDAQ:HGEN

Humanigen News Headlines

$2.03
+0.15 (+7.98%)
(As of 05/18/2022 04:00 PM ET)
Add
Compare
Today's Range
$1.80
$2.04
50-Day Range
$1.76
$3.97
52-Week Range
$1.67
$23.53
Volume
1.14 million shs
Average Volume
1.29 million shs
Market Capitalization
$143.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-1.01
Get Humanigen News Delivered to You Automatically

Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Humanigen Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HGEN
News Sentiment

0.96

0.28

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HGEN Articles
This Week

8

4

HGEN Articles
Average Week



Humanigen (NASDAQ:HGEN) News Headlines Today

SourceHeadline
finance.yahoo.com logo"The Charming Taste of Europe" Participated in SIAL Canada, North America's Biggest Food-Innovation Trade Show - Yahoo Finance
finance.yahoo.com - May 13 at 5:25 PM
finance.yahoo.com logoLand Betterment Impact Minute #37: Huge Economic Opportunities in Rural Areas Post Covid-19 With Colby Hall of SOAR - Yahoo Finance
finance.yahoo.com - May 13 at 12:24 PM
businessinsider.com logoList: Biotech Companies at Highest Risk of Bankruptcy - Business Insider
businessinsider.com - May 13 at 12:24 PM
finance.yahoo.com logoGlobal Sports Compression Garments Market Would Register a Healthy Growth of USD 7,305.04 Million By 2030 - Yahoo Finance
finance.yahoo.com - May 13 at 1:29 AM
finance.yahoo.com logoThe Canadian Business Hall of Fame welcomes 600 Guests for the 43rd Induction Ceremony & Celebration in support of JA Canada - Yahoo Finance
finance.yahoo.com - May 12 at 2:49 PM
finance.yahoo.com logoYardi Recognised at 2022 SBR Technology Excellence Awards - Yahoo Finance
finance.yahoo.com - May 12 at 10:02 AM
nasdaq.com logoPre-market Movers: BROS, SLS, DTST, BYND, CISO… - Nasdaq
nasdaq.com - May 12 at 10:02 AM
finance.yahoo.com logoPneumagen Announces Positive Top Line Results from Phase 1 Study Evaluating Neumifil, a Product Designed for the Prevention and Treatment of Viral Respiratory Tract Infections - Yahoo Finance
finance.yahoo.com - May 12 at 7:59 AM
nasdaq.com logoHumanigen: A ‘Transformative Year’ Awaits, Says Analyst - Nasdaq
nasdaq.com - May 12 at 12:17 AM
finance.yahoo.com logoHumanigen: A ‘Transformative Year’ Awaits, Says Analyst
finance.yahoo.com - May 11 at 11:17 PM
finance.yahoo.com logoInvestors in Humanigen (NASDAQ:HGEN) from a year ago are still down 89%, even after 14% gain this past week
finance.yahoo.com - May 9 at 9:52 AM
MarketBeat logoHumanigen, Inc. (NASDAQ:HGEN) Given Average Rating of "Hold" by Brokerages
americanbankingnews.com - May 7 at 4:42 AM
businesswire.com logoHumanigen Reports First Quarter 2022 Financial Results - Business Wire
businesswire.com - May 6 at 12:56 AM
finance.yahoo.com logoHumanigen Reports First Quarter 2022 Financial Results - Yahoo Finance
finance.yahoo.com - May 5 at 7:55 PM
finance.yahoo.com logoHumanigen Reports First Quarter 2022 Financial Results
finance.yahoo.com - May 5 at 7:55 PM
businesswire.com logoHumanigen Announces Participation and Presentation at Multiple Conferences in May - Business Wire
businesswire.com - May 4 at 9:20 AM
finance.yahoo.com logoHumanigen Announces Participation and Presentation at Multiple Conferences in May - Yahoo Finance
finance.yahoo.com - May 4 at 8:58 AM
finance.yahoo.com logoHumanigen Announces Participation and Presentation at Multiple Conferences in May
finance.yahoo.com - May 4 at 8:58 AM
businesswire.com logoGM-CSF Knock-out CAR-T Study Published in Peer-Reviewed Journal Leukemia - Business Wire
businesswire.com - April 20 at 11:28 PM
streetinsider.com logoHumanigen Inc. (HGEN) Announces Publication of GM-CSF Knock-out CAR-T Study - StreetInsider.com
streetinsider.com - April 20 at 8:27 AM
businesswire.com logoHumanigen Announces Peer-Reviewed Publication Demonstrating the Potential Clinical and Economic Benefits of Lenzilumab from the Perspective of the NHS - Business Wire
businesswire.com - April 19 at 10:10 AM
finance.yahoo.com logoHumanigen, Inc.'s (NASDAQ:HGEN) Path To Profitability
finance.yahoo.com - April 7 at 4:15 PM
reuters.com logoDrugmakers, scientists begin the hunt for long COVID treatments - Reuters.com
reuters.com - March 26 at 5:09 AM
seekingalpha.com logoHumanigen rallies 13% after chief scientific officer buys more shares
seekingalpha.com - March 16 at 4:00 AM
seekingalpha.com logoHumanigen gains the most in nearly a year after new insider filing by science chief
seekingalpha.com - March 11 at 2:10 PM
uk.investing.com logoInsiders Buying These 4 Penny Stocks By Benzinga - Investing.com UK
uk.investing.com - March 7 at 10:52 AM
seekingalpha.com logoHumanigen gains as CEO more than doubles stake
seekingalpha.com - March 4 at 3:56 PM
benzinga.com logoHumanigen's Return On Capital Employed Insights - Benzinga
benzinga.com - March 3 at 9:50 AM
businesswire.com logoHumanigen Reports Year-End 2021 Financial Results - Business Wire
businesswire.com - February 28 at 4:13 PM
businesswire.com logoHumanigen to Present and Participate at Multiple Investor Events in March - Business Wire
businesswire.com - February 25 at 1:46 PM
finance.yahoo.com logoHumanigen to Present and Participate at Multiple Investor Events in March - Yahoo Finance
finance.yahoo.com - February 25 at 8:46 AM
finance.yahoo.com logoHumanigen to Present and Participate at Multiple Investor Events in March
finance.yahoo.com - February 25 at 8:46 AM
finance.yahoo.com logoTRYP THERAPEUTICS INC. ANNOUNCES BOARD CHANGES AND CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT - Yahoo Finance
finance.yahoo.com - February 22 at 7:52 AM
benzinga.com logo25 Stocks Moving in Monday's Pre-Market Session - Benzinga - Benzinga
benzinga.com - February 14 at 9:09 AM
businesswire.com logoHumanigen to Present at BIO CEO & Investor Conference - Business Wire
businesswire.com - February 12 at 10:52 PM
finance.yahoo.com logoHumanigen to Present at BIO CEO & Investor Conference
finance.yahoo.com - February 11 at 6:48 AM
businesswire.com logoHumanigen Launches Managed Access Program for Lenzilumab - Business Wire
businesswire.com - February 10 at 1:02 AM
benzinga.com logoThe Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testi - Benzinga
benzinga.com - February 9 at 4:36 PM
reuters.com logoChipotle, Zosano, CVS, Omnicom - Reuters
reuters.com - February 9 at 3:01 PM
finance.yahoo.com logoHumanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France - Yahoo Finance
finance.yahoo.com - February 9 at 12:48 AM
businesswire.com logoHumanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France - Business Wire
businesswire.com - February 9 at 12:07 AM
finance.yahoo.com logoHumanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France
finance.yahoo.com - February 9 at 12:07 AM
finance.yahoo.com logoWhat Kind Of Shareholders Own Humanigen, Inc. (NASDAQ:HGEN)?
finance.yahoo.com - February 6 at 10:25 AM
nasdaq.com logoHumanigen: New Publication Details Lenzilumab’s Economic Benefits, Says Analyst - Nasdaq
nasdaq.com - January 19 at 7:06 PM
businesswire.com logoHumanigen Announces Peer-Reviewed Publication in The Journal of Medical Economics Demonstrating the Clinical and Economic Benefits of Lenzilumab - Business Wire
businesswire.com - January 18 at 10:05 AM
finance.yahoo.com logoHumanigen Aligns with FDA on Potential Registration Phase 3 Study for Lenzilumab with CAR-T - Yahoo Finance
finance.yahoo.com - January 12 at 4:22 AM
finance.yahoo.com logoHumanigen Aligns with FDA on Potential Registration Phase 3 Study for Lenzilumab with CAR-T
finance.yahoo.com - January 10 at 6:31 AM
finance.yahoo.com logoAligos Halting Further Development of STOPS™ Drug Candidate, ALG-010133 - Yahoo Finance
finance.yahoo.com - January 7 at 3:36 AM
finance.yahoo.com logoAMC Gets Serious About Anime By Acquiring Sentai Filmworks And Hidive - Yahoo! Voices
finance.yahoo.com - January 7 at 3:36 AM
finance.yahoo.com logoCocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205 - Yahoo Finance
finance.yahoo.com - January 7 at 3:36 AM
Get Humanigen News Delivered to You Automatically

Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.